EUVIMEDEUVIMED entdecken
Crossref

Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid

Deepak Kumar Sahel, Sangam Giri Goswami, Reena Jatyan, Anupma Kumari, Anupama Mittal, Sivaprakash Ramalingam, Deepak Chitkara iD

Macromolecular Rapid Communications · 2023

DOI: 10.1002/marc.202300101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Rapid Communications, 2023. Verfasst von Deepak Kumar Sahel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS Pilani), Pilani Campus, Vidya Vihar, Pilani, Rajasthan, 333031, India. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Department of Biotechnology, India, Indian Council of Medical Research, Senior Research Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR/Cas9 has proven its accuracy and precision for gene editing by making a double‐strand break at the predetermined site. Despite being a mainstream gene editing tool, CRISPR/Cas9 has limitations for its in vivo delivery due to the physico‐chemical properties such as high molecular weight, supranegative charge, degradation in the presence of nucleases, etc. Hereby, a cationic lipopolymer is explored for its efficiency in delivering CRISPR/Cas9 plasmid (pCas9) in vitro and in vivo. The lipopolymer is utilized to form blank cationic nanoplexes having a zeta potential of +15.8 ± 0.7 mV. Being cationic, the blank nanoplexes are able to condense the pCas9 plasmid at a ratio of 1:20 with a complexation efficiency of ≈98% and show a size and zeta potential of ≈141 ± 16 nm and 4.2 mV ± 0.7, respectively. The pCas9‐loaded nanoplexes show a transfection efficiency of ≈69% in ARPE‐19 cells and show ≈22% of indel frequency, indicating the successful translation of Cas9 protein and guide RNA in the cytosol. Further, they are found to be stable under in vivo environment when given intravenously in Swiss albino mice. These lipopolymeric nanoplexes can be a potential carrier for CRISPR plasmids for genome editing applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingAnimalsMiceCRISPR-Associated Protein 9TransfectionPlasmids

Stichwörter der Autor:innen

CRISPR/Cas9cationic polymersgene editingnanoplexes

Substanzen

CRISPR-Associated Protein 9

Autor:innen und Institutionen

  • Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS Pilani), Pilani Campus, Vidya Vihar, Pilani, Rajasthan, 333031, India.
  • CSIR-Institute of Genomics and Integrated Biology, New Delhi, 110025, India.
  • Centre for Comparative Medicine, Institute of Liver and Biliary Sciences (ILBS), New Delhi, 110070, India.

ORCID-Profile: Deepak Chitkara

Förderung

  • Department of Biotechnology, India
  • Indian Council of Medical Research
  • Senior Research Fellowship

Zitieren

APA

Sahel, D. K., Goswami, S. G., Jatyan, R., Kumari, A., Mittal, A., Ramalingam, S., & Chitkara, D. (2023). Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid. Macromolecular Rapid Communications. https://doi.org/10.1002/marc.202300101

Vancouver

Sahel DK, Goswami SG, Jatyan R, Kumari A, Mittal A, Ramalingam S, et al. Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid. Macromolecular Rapid Communications. 2023. doi:10.1002/marc.202300101

BibTeX
@article{Sahel2023,
  author = {Sahel, Deepak Kumar and Goswami, Sangam Giri and Jatyan, Reena and Kumari, Anupma and Mittal, Anupama and Ramalingam, Sivaprakash and Chitkara, Deepak},
  title = {Lipopolymeric Nanocarrier Enables Effective Delivery of CRISPR/Cas9 Expressing Plasmid},
  journal = {Macromolecular Rapid Communications},
  year = {2023},
  doi = {10.1002/marc.202300101}
}
Kostenlos starten →